Evolving rare B cell lineages for an effective HIV vaccine. Article uri icon

Overview

abstract

  • Clinical trials show that strategies to elicit the production of broadly neutralizing antibodies have a promising start.

publication date

  • July 31, 2025

Research

keywords

  • AIDS Vaccines
  • B-Lymphocytes
  • Broadly Neutralizing Antibodies
  • HIV Antibodies
  • HIV Infections
  • HIV-1

Identity

PubMed Central ID

  • PMC12951596

Scopus Document Identifier

  • 105012804054

Digital Object Identifier (DOI)

  • 10.1126/science.adz6436

PubMed ID

  • 40743359

Additional Document Info

volume

  • 389

issue

  • 6759